Edition:
United States

Cardinal Health Inc (CAH)

CAH on New York Consolidated

46.24USD
16 Jul 2019
Change (% chg)

$-1.26 (-2.65%)
Prev Close
$47.50
Open
$47.18
Day's High
$47.25
Day's Low
$46.09
Volume
1,952,613
Avg. Vol
2,907,163
52-wk High
$58.31
52-wk Low
$42.01

Latest Key Developments (Source: Significant Developments)

Cardinal Health Says Jorge Gomez, CFO, Has Notified Co That He Will Leave Co Effective August 9
Monday, 8 Jul 2019 08:13am EDT 

July 8 (Reuters) - Cardinal Health Inc ::CARDINAL HEALTH INC - JORGE M. GOMEZ, CFO, HAS NOTIFIED CO THAT HE WILL LEAVE CO EFFECTIVE AUGUST 9, 2019 - SEC FILING.CARDINAL HEALTH INC - CEO MICHAEL C. KAUFMANN, 56, WILL ASSUME ADDITIONAL ROLE OF INTERIM CFO EFFECTIVE AUGUST 9.  Full Article

Cardinal Health Inc Says Entered Into Second Amended And Restated Five-Year Credit Agreement
Friday, 28 Jun 2019 09:27am EDT 

June 28 (Reuters) - Cardinal Health Inc ::CARDINAL HEALTH INC - ENTERED INTO A SECOND AMENDED AND RESTATED FIVE-YEAR CREDIT AGREEMENT.CARDINAL HEALTH INC - SECOND AMENDED AND RESTATED CREDIT AGREEMENT ALLOWS COMPANY ACCESS TO $2.0 BILLION OF REVOLVING CREDIT.CARDINAL HEALTH INC - AMENDMENT EXTENDS TERM OF REVOLVING CREDIT FACILITY TO JUNE 27, 2024.  Full Article

Medically Home Group Raises $10 Mln Towards Its Series B Funding
Tuesday, 28 May 2019 06:00am EDT 

May 28 (Reuters) - Medically Home Group Inc::MEDICALLY HOME GROUP RAISES $10 MILLION TOWARDS ITS SERIES B FUNDING.MEDICALLY HOME GROUP - CARDINAL HEALTH HAS MADE AN INVESTMENT IN CO'S SERIES B ROUND.  Full Article

Cardinal Health Inc - Sees Mid-Single Digit Percentage Growth in 2019 Revenue
Thursday, 7 Feb 2019 07:56am EST 

Feb 7 (Reuters) - Cardinal Health Inc ::CARDINAL HEALTH INC - SEES 2019 REVENUE MID-SINGLE DIGIT PERCENTAGE GROWTH.CARDINAL HEALTH INC - SEES 2019 CAPITAL EXPENDITURES $360M - $390M.CARDINAL HEALTH INC SEES 2019 PHARMACEUTICAL SEGMENT REVENUE WITH MID TO HIGH-SINGLE DIGIT PERCENTAGE GROWTH.CARDINAL HEALTH INC SEES 2019 MEDICAL SEGMENT REVENUE APPROXIMATELY FLAT - PRESENTATION.CARDINAL HEALTH INC SEES 2019 MEDICAL SEGMENT PROFIT WITH MID TO HIGH-SINGLE DIGIT PERCENTAGE GROWTH.CARDINAL HEALTH INC SEES 2019 PHARMACEUTICAL SEGMENT WITH HIGH-SINGLE TO LOW-DOUBLE DIGIT PERCENTAGE DECLINE.  Full Article

Cardinal Health Reports Second Quarter Results For 2019
Thursday, 7 Feb 2019 06:55am EST 

Feb 7 (Reuters) - Cardinal Health Inc ::CARDINAL HEALTH REPORTS SECOND QUARTER RESULTS FOR FISCAL YEAR 2019.Q2 NON-GAAP EARNINGS PER SHARE $1.29.Q2 GAAP EARNINGS PER SHARE $0.93.Q2 REVENUE $37.7 BILLION VERSUS REFINITIV IBES ESTIMATE OF $36.1 BILLION.Q2 EARNINGS PER SHARE ESTIMATE $1.09 -- REFINITIV IBES DATA.RAISES FY 2019 NON-GAAP EARNINGS PER SHARE VIEW TO $4.97 TO $5.17.COMPANY RAISES FY19 GUIDANCE.RAISES FY19 GUIDANCE.FY2019 EARNINGS PER SHARE VIEW $5.00 -- REFINITIV IBES DATA.Q2 REVENUE FOR PHARMACEUTICAL SEGMENT INCREASED 8 PERCENT TO $33.7 BILLION.WELL-POSITIONED TO EXCEED OUR COST-SAVINGS TARGETS FOR THE ENTERPRISE.  Full Article

Cardinal Health Recommends Shareholders Reject The Below-Market Mini-Tender Offer By TRC Capital Corporation
Friday, 9 Mar 2018 07:30am EST 

March 9 (Reuters) - Cardinal Health Inc ::CARDINAL HEALTH RECOMMENDS SHAREHOLDERS REJECT THE BELOW-MARKET MINI-TENDER OFFER BY TRC CAPITAL CORPORATION.CARDINAL HEALTH - RECEIVED NOTICE OF UNSOLICITED "MINI-TENDER" OFFER BY TRC CAPITAL TO PURCHASE UP TO 2 MILLION OF CO'S COMMON SHARES.CARDINAL HEALTH INC - TRC CAPITAL'S "MINI-TENDER" OFFER IS FOR OFFER PRICE OF $65.85 PER CARDINAL HEALTH SHARE.  Full Article

Cardinal Health Reports Q2 Adj. Earnings Per Share $1.31
Thursday, 8 Feb 2018 07:00am EST 

Feb 8 (Reuters) - Cardinal Health Inc ::CARDINAL HEALTH REPORTS SECOND-QUARTER RESULTS FOR FISCAL YEAR 2018.Q2 REVENUE $35.2 BILLION.RAISES FY 2018 NON-GAAP EARNINGS PER SHARE VIEW TO $5.25 TO $5.50.Q2 NON-GAAP EARNINGS PER SHARE $1.31 EXCLUDING ITEMS.COMPANY RAISES FY18 OUTLOOK TO REFLECT BENEFITS OF U.S. TAX REFORM.BOARD OF DIRECTORS APPROVES NEW $1 BILLION SHARE REPURCHASE AUTHORIZATION.CARDINAL HEALTH-FOR QUARTER ENDED DEC. 31, 2017, APPLICATION OF LOWER TAX RATE TO FISCAL YEAR-TO-DATE U.S. EARNINGS RESULTED IN A BENEFIT OF $0.20/SHARE.COMPANY IS RAISING ITS OUTLOOK FOR FISCAL 2018 NON-GAAP EPS TO $5.25-$5.50.SECOND-QUARTER REVENUE FOR PHARMACEUTICAL SEGMENT INCREASED 5 PERCENT TO $31.1 BILLION.QTRLY GAAP DILUTED EARNINGS PER SHARE INCREASES 226 PERCENT TO $3.33.AS PART OF U.S. TAX REFORM, CO RECORDED TRANSITIONAL TAX BENEFITS TOTALING $2.83PER SHARE IN QUARTER.EXCLUDING A $0.20 BENEFIT FROM TAX REFORM, QTRLY NON-GAAP EPS IS $1.31.QTRLY NON-GAAP EPS INCREASED 13 PERCENT TO $1.51.Q2 REVENUE VIEW $34.64 BILLION -- THOMSON REUTERS I/B/E/S.  Full Article

Cordis And Medinol Announce FDA Approval Of EluNIR Drug-Eluting Stent System
Thursday, 30 Nov 2017 08:30am EST 

Nov 30 (Reuters) - Cardinal Health Inc ::CORDIS AND MEDINOL ANNOUNCE FDA APPROVAL OF THE INNOVATIVE ELUNIR DRUG-ELUTING STENT SYSTEM.  Full Article

Shanghai Pharmaceuticals' unit‍ signs deal to acquire Cardinal in Malaysia
Tuesday, 14 Nov 2017 07:58pm EST 

Nov 15 (Reuters) - Shanghai Pharmaceuticals Holding Co Ltd <601607.SS>:Says its unit‍ Century Global signs deal to acquire Cardinal Malaysia for about $557 million.  Full Article

Cardinal Health says shareholders re-elected all 11 members to board in preliminary voting ​
Wednesday, 8 Nov 2017 04:15pm EST 

Nov 8 (Reuters) - Cardinal Health Inc :Cardinal Health - ‍based on preliminary results of shareholder voting at co's annual meeting, shareholders re-elected all 11 members to board​.  Full Article

Cardinal Health must turn over suspicious-drug audit in opioid MDL

Cardinal Health Inc has lost a bid to avoid turning over the results of a 2008 audit of its system for identifying suspicious drug orders to lawyers for two Ohio counties who claim the drug wholesale distributor helped fuel the opioid epidemic.